Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ala-Hurula

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Clinical Pharmacology|January 1, 1982
Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraineV Ala-Hurula
Cephalalgia : an International Journal of Headache|December 1, 1982
Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrationsV Ala-Hurula, V Myllylä, E Hokkanen
Upsala Journal of Medical Sciences. Supplement|January 1, 1980
Systemic availability of ergotamine tartrate in continuous medicationV V Myllylä, V Ala-Hurula, P Arvela, et al.
Upsala Journal of Medical Sciences. Supplement|January 1, 1980
Systemic availability of ergotamine tartrate in healthy subjects after single and repeated oral dosesV Ala-Hurula, V V Myllylä, P Arvela, et al.
Acta Neurologica Scandinavica|September 1, 1979
Juvenile amyotrophic lateral sclerosis. A report of two cases in a single familyV V Myllylä, E Toivakka, V Ala-Hurula, et al.
European Journal of Clinical Pharmacology|February 19, 1979
Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administrationV Ala-Hurula, V V Myllylä, P Arvela, et al.
Annals of Neurology|September 1, 1994
Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological descriptionM Haltia, M Viitanen, R Sulkava, et al.
Nature Genetics|May 1, 1995
Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutaseP M Andersen, P Nilsson, V Ala-Hurula, et al.
Brain : a Journal of Neurology|August 1, 1996
Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patientsP M Andersen, L Forsgren, M Binzer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Pharmacology|January 1, 1982
Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraineV Ala-Hurula
Cephalalgia : an International Journal of Headache|December 1, 1982
Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrationsV Ala-Hurula, V Myllylä, E Hokkanen
Upsala Journal of Medical Sciences. Supplement|January 1, 1980
Systemic availability of ergotamine tartrate in continuous medicationV V Myllylä, V Ala-Hurula, P Arvela, et al.
Upsala Journal of Medical Sciences. Supplement|January 1, 1980
Systemic availability of ergotamine tartrate in healthy subjects after single and repeated oral dosesV Ala-Hurula, V V Myllylä, P Arvela, et al.
Acta Neurologica Scandinavica|September 1, 1979
Juvenile amyotrophic lateral sclerosis. A report of two cases in a single familyV V Myllylä, E Toivakka, V Ala-Hurula, et al.
European Journal of Clinical Pharmacology|February 19, 1979
Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administrationV Ala-Hurula, V V Myllylä, P Arvela, et al.
Annals of Neurology|September 1, 1994
Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological descriptionM Haltia, M Viitanen, R Sulkava, et al.
Nature Genetics|May 1, 1995
Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutaseP M Andersen, P Nilsson, V Ala-Hurula, et al.
Brain : a Journal of Neurology|August 1, 1996
Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patientsP M Andersen, L Forsgren, M Binzer, et al.
Pageof 1